Hepatocellular Carcinoma Drugs (PD-1/PD-L1 Inhibitors, Tyrosine Kinase Inhibitors) Industry Report 2024: A $1.62 Billion Market Opportunity by 2028
24 janv. 2024 13h42 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global hepatocellular...
Global Hepatocellular Carcinoma Treatment Market 2021-2025: Market Sizing, Market Forecast and Key Vendor Profiles
08 mars 2021 07h33 HE
|
Research and Markets
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Global Hepatocellular Carcinoma Treatment Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The hepatocellular carcinoma...